The change ties hospital reimbursement directly to SEP-1 performance, raising financial stakes for front-line decision-making and amplifying tensions between quality metrics and antibiotic stewardship. Improved diagnostics and support are needed to protect patient outcomes while preventing penalties and curbing antimicrobial resistance.
CMS has shifted SEP-1 sepsis bundle performance from a reporting requirement into value-based purchasing, exposing hospitals to payments or penalties based on compliance. National SEP-1 compliance averages roughly 65%, but clinicians face a crucial timing mismatch: they must decide in the emergency department whether to initiate the bundle before definitive sepsis determination. Compliance is assessed after discharge when charts are reviewed, creating pressure to treat broadly to avoid penalties. Speakers call for better rapid diagnostics and decision support to balance timely care with avoiding unnecessary interventions like excess antibiotics.
Comments
Want to join the conversation?
Loading comments...